PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of brjgenpracRCGP homepageJ R Coll Gen Pract at PubMed CentralBJGP at RCGPBJGP at RCGP
 
Br J Gen Pract. 2001 June; 51(467): 473–477.
PMCID: PMC1314030

Topical antibiotics for acute bacterial conjunctivitis: a systematic review.

Abstract

There has been uncertainty about whether antibiotic therapy confers significant benefit in the treatment of acute bacterial conjunctivitis. This study aimed to assess the efficacy of antibiotic therapy in the management of acute bacterial conjunctivitis. Using standard Cochrane search methods, we identified double-blind randomised controlled trials in which any form of antibiotic treatment (topical, systemic or combination) had been compared with placebo in the management of acute bacterial conjunctivitis. Data extraction and analysis followed a pre-defined protocol. Meta-analysis was performed to obtain summary measures of relative risk. Six published trials were identified, of which three fulfilled the eligibility criteria for inclusion in this review. The trials were heterogeneous in terms of their inclusion and exclusion criteria, the nature of the intervention, and the outcome measures assessed. Meta-analysis indicates that acute bacterial conjunctivitis is frequently a self-limiting condition, as clinical remission occurred by days 2 to 5 in 64% (95% confidence interval (CI) = 57-71) of those treated with placebo. Treatment with antibiotics was, however, associated with significantly better rates of clinical remission (days 2 to 5: relative risk (RR) = 1.31, 95% CI = 1.11-1.55), with a suggestion that this benefit was maintained for late clinical remission (days 6 to 10: RR = 1.27, 95% CI = 1.00-1.61). Acute bacterial conjunctivitis is frequently a self-limiting condition but the use of antibiotics is associated with significantly improved rates of early clinical remission, and early and late microbiological remission. Since trials to date have been conducted in selected specialist care patient populations, generalisation of these results to a primary care-based population should be undertaken with a degree of caution.

Full Text

The Full Text of this article is available as a PDF (73K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Horton R. Evidence and primary care. Lancet. 1999 Feb 20;353(9153):609–610. [PubMed]
  • Heggie AD. Incidence and etiology of conjunctivitis in Navy recruits. Mil Med. 1990 Jan;155(1):1–3. [PubMed]
  • Dart JK. Eye disease at a community health centre. Br Med J (Clin Res Ed) 1986 Dec 6;293(6560):1477–1480. [PMC free article] [PubMed]
  • Fitch CP, Rapoza PA, Owens S, Murillo-Lopez F, Johnson RA, Quinn TC, Pepose JS, Taylor HR. Epidemiology and diagnosis of acute conjunctivitis at an inner-city hospital. Ophthalmology. 1989 Aug;96(8):1215–1220. [PubMed]
  • Gigliotti F, Williams WT, Hayden FG, Hendley JO, Benjamin J, Dickens M, Gleason C, Perriello VA, Wood J. Etiology of acute conjunctivitis in children. J Pediatr. 1981 Apr;98(4):531–536. [PubMed]
  • Mahajan VM. Acute bacterial infections of the eye: their aetiology and treatment. Br J Ophthalmol. 1983 Mar;67(3):191–194. [PMC free article] [PubMed]
  • Perkins RE, Kundsin RB, Pratt MV, Abrahamsen I, Leibowitz HM. Bacteriology of normal and infected conjunctiva. J Clin Microbiol. 1975 Feb;1(2):147–149. [PMC free article] [PubMed]
  • McDonnell PJ. How do general practitioners manage eye disease in the community? Br J Ophthalmol. 1988 Oct;72(10):733–736. [PMC free article] [PubMed]
  • Morrow GL, Abbott RL. Conjunctivitis. Am Fam Physician. 1998 Feb 15;57(4):735–746. [PubMed]
  • Gigliotti F, Hendley JO, Morgan J, Michaels R, Dickens M, Lohr J. Efficacy of topical antibiotic therapy in acute conjunctivitis in children. J Pediatr. 1984 Apr;104(4):623–626. [PubMed]
  • Leibowitz HM. Antibacterial effectiveness of ciprofloxacin 0.3% ophthalmic solution in the treatment of bacterial conjunctivitis. Am J Ophthalmol. 1991 Oct;112(4 Suppl):29S–33S. [PubMed]
  • Miller IM, Wittreich J, Vogel R, Cook TJ. The safety and efficacy of topical norfloxacin compared with placebo in the treatment of acute, bacterial conjunctivitis. The Norfloxacin-Placebo Ocular Study Group. Eur J Ophthalmol. 1992 Apr-Jun;2(2):58–66. [PubMed]
  • Leibowitz HM, Pratt MV, Flagstad IJ, Berrospi AR, Kundsin R. Human conjunctivitis. II. Treatment. Arch Ophthalmol. 1976 Oct;94(10):1752–1756. [PubMed]
  • Chaudhry NA, Flynn HW, Jr, Murray TG, Tabandeh H, Mello MO, Jr, Miller D. Emerging ciprofloxacin-resistant Pseudomonas aeruginosa. Am J Ophthalmol. 1999 Oct;128(4):509–510. [PubMed]
  • Goldstein MH, Kowalski RP, Gordon YJ. Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review. Ophthalmology. 1999 Jul;106(7):1313–1318. [PubMed]
  • Little P, Williamson I, Warner G, Gould C, Gantley M, Kinmonth AL. Open randomised trial of prescribing strategies in managing sore throat. BMJ. 1997 Mar 8;314(7082):722–727. [PMC free article] [PubMed]
  • Jauch A, Fsadni M, Gamba G. Meta-analysis of six clinical phase III studies comparing lomefloxacin 0.3% eye drops twice daily to five standard antibiotics in patients with acute bacterial conjunctivitis. Graefes Arch Clin Exp Ophthalmol. 1999 Sep;237(9):705–713. [PubMed]
  • Malminiemi K, Kari O, Latvala ML, Voutilainen R, Miettinen A, Jauch A. Topical lomefloxacin twice daily compared with fucidic acid in acute bacterial conjunctivitis. Acta Ophthalmol Scand. 1996 Jun;74(3):280–284. [PubMed]
  • Trimethoprim-polymyxin B sulphate ophthalmic ointment versus chloramphenicol ophthalmic ointment in the treatment of bacterial conjunctivitis--a review of four clinical studies. The Trimethoprim-Polymyxin B Sulphate Ophthalmic Ointment Study Group. J Antimicrob Chemother. 1989 Feb;23(2):261–266. [PubMed]
  • Behrens-Baumann W, Quentin CD, Gibson JR, Calthrop JG, Harvey SG, Booth K. Trimethoprim-polymyxin B sulphate ophthalmic ointment in the treatment of bacterial conjunctivitis: a double-blind study versus chloramphenicol ophthalmic ointment. Curr Med Res Opin. 1988;11(4):227–231. [PubMed]
  • van Rensburg SF, Gibson JR, Harvey SG, Burke CA. Trimethoprim-polymyxin ophthalmic solution versus chloramphenicol ophthalmic solution in the treatment of bacterial conjunctivitis. Pharmatherapeutica. 1982;3(4):274–277. [PubMed]
  • Gibson JR. Trimethoprim-polymyxin B ophthalmic solution in the treatment of presumptive bacterial conjunctivitis--a multicentre trial of its efficacy versus neomycin-polymyxin B-gramicidin and chloramphenicol ophthalmic solutions. J Antimicrob Chemother. 1983 Mar;11(3):217–221. [PubMed]
  • Genée E, Schlechtweg C, Bauerreiss P, Gibson JR. Trimethoprim-polymyxin eye drops versus neomycin-polymyxin-gramicidin eye drops in the treatment of presumptive bacterial conjunctivitis - a double-blind study. Ophthalmologica. 1982;184(2):92–96. [PubMed]
  • Hørven I. Acute conjunctivitis. A comparison of fusidic acid viscous eye drops and chloramphenicol. Acta Ophthalmol (Copenh) 1993 Apr;71(2):165–168. [PubMed]
  • Hvidberg J. Fusidic acid in acute conjunctivitis. Single-blind, randomized comparison of fusidic acid and chloramphenicol viscous eye drops. Acta Ophthalmol (Copenh) 1987 Feb;65(1):43–47. [PubMed]
  • Lohr JA, Austin RD, Grossman M, Hayden GF, Knowlton GM, Dudley SM. Comparison of three topical antimicrobials for acute bacterial conjunctivitis. Pediatr Infect Dis J. 1988 Sep;7(9):626–629. [PubMed]
  • Stern GA, Killingsworth DW. Complications of topical antimicrobial agents. Int Ophthalmol Clin. 1989 Fall;29(3):137–142. [PubMed]
  • Lancaster T, Swart AM, Jick H. Risk of serious haematological toxicity with use of chloramphenicol eye drops in a British general practice database. BMJ. 1998 Feb 28;316(7132):667–667. [PMC free article] [PubMed]
  • Wiholm BE, Kelly JP, Kaufman D, Issaragrisil S, Levy M, Anderson T, Shapiro S. Relation of aplastic anaemia to use of chloramphenicol eye drops in two international case-control studies. BMJ. 1998 Feb 28;316(7132):666–666. [PMC free article] [PubMed]

Articles from The British Journal of General Practice are provided here courtesy of Royal College of General Practitioners